SLC2A1 and telomere syndrome: In conclusion, the expression of hypoxic markers, including HIF-1α, CA9, GLUT1 and VEGF is common in patients with STS and is strongly associated with tumor progression, as indicated by the significant association of their expression with higher histological grade and advanced tumor stage.